Conference
Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review
Abstract
Abstract
INTRODUCTION: A randomized crossover design is an efficient way to compare two treatment approaches as patients serve as their own control minimizing between patient variability; however, for the crossover design to be valid the patients disease must be stable during observation period. A crossover design was considered for exploring the age of transfused red cells on quality of life (QoL) in patients with …
Authors
Sholapur NS; Hillis CM; Crowther MA; Leber B; Khokhar F; Cook R; Barr R; Heddle NM
Volume
126
Publisher
American Society of Hematology
Publication Date
December 3, 2015
DOI
10.1182/blood.v126.23.5252.5252
Conference proceedings
Blood
Issue
23
ISSN
0006-4971